搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
India Today on MSN
2 天
Air pollution is the leading cause of COPD: Why is this lung disease deadly
Delhi's air pollution has reached severe levels, raising health concerns for those with chronic respiratory diseases like ...
emjreviews.com
8 天
Physical Activity Reduces Exacerbations in COPD Patients on Dual Bronchodilators
Discover how moderate-to-vigorous physical activity can reduce exacerbations and corticosteroid use in COPD patients on dual ...
15 天
周贤梅教授团队在BMC Medicine期刊发表系统性糖皮质激素使用与入住ICU ...
近日,江苏省中医院(南京中医药大学附属医院)呼吸与危重症医学科周贤梅教授团队在内科学领域国际著名期刊BMC Medicine(IF=7.0,中科院一区)发表标题为“Association of systemic corticosteroid use ...
News Medical on MSN
1 天
Study focuses on COPD progression in younger populations
Researchers are exploring how small airway abnormalities in younger smokers could help identify who is at risk of developing ...
Too Old to Operate
3 天
The Latest Insights & Clinical Updates From COPD Research
This roundup offers a look at the latest insights from the clinicians and researchers investigating chronic obstructive pulmonary disease and asthma.
3 天
on MSN
Study examines development of early COPD in ages 30 to 55
Researchers are exploring how small airway abnormalities in younger smokers could help identify who is at risk of developing ...
Indiatimes
23 小时
Poor air lingers two weeks after Diwali, patients take longer to recover
particularly among those suffering from asthma and COPD (chronic obstructive pulmonary disease). Pulmonologist Dr Himanshu ...
EurekAlert!
4 天
Novel SOURCE study examining development of early COPD in ages 30 to 55
Researchers are exploring how small airway abnormalities in younger smokers could help identify who is at risk of developing COPD and establish how the chronic lung disease progresses.
Benzinga.com
4 天
Regeneron/Sanofi's Dupixent Approval Signals Major Treatment Breakthrough For Smokers' Lung ...
The BOREAS Phase III trial showed DUPIXENT reduced exacerbations by 30% and improved lung function by 160 mL at 52 weeks.
Yahoo Finance
5 天
myBiometry raises funding to advance development of fenoTRACK device
Type 2 inflammation is identified as a primary cause in 80% of asthma cases and 30%-40% of COPD cases. The data obtained from ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈